SG11201510802QA - Combination therapy for prostate cancer using botanical compositions and docetaxel - Google Patents

Combination therapy for prostate cancer using botanical compositions and docetaxel

Info

Publication number
SG11201510802QA
SG11201510802QA SG11201510802QA SG11201510802QA SG11201510802QA SG 11201510802Q A SG11201510802Q A SG 11201510802QA SG 11201510802Q A SG11201510802Q A SG 11201510802QA SG 11201510802Q A SG11201510802Q A SG 11201510802QA SG 11201510802Q A SG11201510802Q A SG 11201510802QA
Authority
SG
Singapore
Prior art keywords
docetaxel
prostate cancer
combination therapy
botanical compositions
botanical
Prior art date
Application number
SG11201510802QA
Other languages
English (en)
Inventor
James Dao
Jeffery Dao
William Gerwick
Lena Gerwick
Maryann Jordan
Leslie Wilson
Original Assignee
Genyous Biomed Internat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genyous Biomed Internat filed Critical Genyous Biomed Internat
Publication of SG11201510802QA publication Critical patent/SG11201510802QA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/074Ganoderma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537Salvia (sage)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539Scutellaria (skullcap)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SG11201510802QA 2013-06-03 2014-06-03 Combination therapy for prostate cancer using botanical compositions and docetaxel SG11201510802QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361830626P 2013-06-03 2013-06-03
PCT/US2014/040769 WO2014197519A1 (en) 2013-06-03 2014-06-03 Combination therapy for prostate cancer using botanical compositions and docetaxel

Publications (1)

Publication Number Publication Date
SG11201510802QA true SG11201510802QA (en) 2016-02-26

Family

ID=52008544

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201510802QA SG11201510802QA (en) 2013-06-03 2014-06-03 Combination therapy for prostate cancer using botanical compositions and docetaxel

Country Status (7)

Country Link
US (1) US20160143971A1 (https=)
EP (1) EP3003490B1 (https=)
JP (1) JP2016523849A (https=)
CN (1) CN105636647A (https=)
CA (1) CA2951110A1 (https=)
SG (1) SG11201510802QA (https=)
WO (1) WO2014197519A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018217237A1 (en) * 2017-05-26 2018-11-29 Genyous Biomed International Combination therapy for cancer using botanical compositions and enzalutamide
US10835538B2 (en) * 2018-03-28 2020-11-17 Nymox Corporation Method of treating benign prostatic hyperlasia with antibiotics
CN108836994B (zh) * 2018-07-25 2021-06-18 南京林业大学 一种人工林树皮皂苷类活性成分的提取方法
AR133093A1 (es) * 2023-06-30 2025-08-27 Future Biome Corp Mezclas de polisacáridos de ganoderma sessile, composiciones y métodos relacionados
CN117064899B (zh) * 2023-10-13 2024-01-23 暨南大学附属第一医院(广州华侨医院) 灵芝酸a在制备治疗去势抵抗性前列腺癌的药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395770B1 (en) * 1995-10-26 2002-05-28 Baker Norton Pharmaceuticals, Inc. Method and compositions for administering taxanes orally to human patients
US5910308A (en) 1997-03-19 1999-06-08 Sante International Inc. Herbal extract composition containing gynostemma pentaphyllum, crataegus pinnatifida and camellia sinensis
US6168795B1 (en) 1998-06-09 2001-01-02 Sant{acute over (e)} International Inc. Method for anticancer therapy using an herbal extract composition
PL1663103T3 (pl) 2003-09-08 2012-05-31 Genyous Biomed Int Inc Kompozycje roślinnych ekstraktów do leczenia nowotworu
RU2006113703A (ru) * 2003-09-22 2007-11-10 Джиниус Байомед Интернэшнл Инк. (Us) Композиции hippophae rhamnoides для терапии рака
US20050196409A1 (en) * 2003-09-24 2005-09-08 James Dao Compositions of botanical extracts for treating malignancy-associated changes
US20110117121A1 (en) * 2006-10-27 2011-05-19 James Dao Compositions for treatment and inhibition of pain
EP2635127B1 (en) * 2010-11-04 2018-10-17 Genyous Biomed International Combination therapy for prostate cancer using botanical compositions and bicalutamide

Also Published As

Publication number Publication date
JP2016523849A (ja) 2016-08-12
US20160143971A1 (en) 2016-05-26
WO2014197519A1 (en) 2014-12-11
EP3003490A1 (en) 2016-04-13
EP3003490A4 (en) 2017-01-25
CN105636647A (zh) 2016-06-01
EP3003490B1 (en) 2019-11-13
CA2951110A1 (en) 2014-12-11

Similar Documents

Publication Publication Date Title
IL276428A (en) A preparation and vaccine for the treatment of lung cancer
IL273090B (en) Methods and preparations for the treatment of cancer
SG10201801433XA (en) Composition and vaccine for treating prostate cancer
IL245281A0 (en) Methods and preparations for the treatment of cancer
IL245731A0 (en) Combined treatment for cancer
LT2925888T (lt) Vėžio gydymo kompozicijos ir būdai
EP3041470A4 (en) Methods and compositions for selective and targeted cancer therapy
GB201322725D0 (en) Cancer therapy
EP3193914A4 (en) Organ protection in psma-targeted radionuclide therapy of prostate cancer
IL238177A0 (en) Methods and preparations for the treatment of cancer
SG10201913730RA (en) Cancer therapy
SG11201507847UA (en) Cancer therapy
EP3004395A4 (en) Compositions and methods for treating cancer
EP3010504A4 (en) Methods and compositions to treat cancer
SG11201510802QA (en) Combination therapy for prostate cancer using botanical compositions and docetaxel
EP2961412A4 (en) CANCER THERAPY
SG11201510804UA (en) Novel formulations of botanical extracts for cancer therapy
EP2984185A4 (en) Methods and compositions for treating cancer
PL3035955T3 (pl) Kompozycja i szczepionka do leczenia raka płuca
WO2014160368A9 (en) Compositions and methods for treating cancer
PL3010513T3 (pl) Skojarzenie RO5503781 i kapecytabiny do leczenia raka
GB201317213D0 (en) Cancer Therapy
GB201322346D0 (en) Combination treatment of cancer
GB201322958D0 (en) Uses of oligouronates in cancer treatment